{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:24:22Z","timestamp":1759073062819,"version":"3.30.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.resmer.2024.101107","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T01:54:29Z","timestamp":1713923669000},"page":"101107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM research registry"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-6230","authenticated-orcid":false,"given":"Ashwin","family":"Basavaraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda E.","family":"Brunton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-8377","authenticated-orcid":false,"given":"Radmila","family":"Choate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6199-7981","authenticated-orcid":false,"given":"Kunal","family":"Jakharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-0613","authenticated-orcid":false,"given":"Christopher","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5243-5394","authenticated-orcid":false,"given":"Timothy R.","family":"Aksamit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1968-1400","authenticated-orcid":false,"given":"Mark L.","family":"Metersky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.resmer.2024.101107_bib0001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMra2202819","article-title":"Bronchiectasis - a clinical review","volume":"387","author":"O'Donnell","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.resmer.2024.101107_bib0002","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.resmer.2024.101107_bib0003","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.resmer.2024.101107_bib0004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.resmer.2024.101107_bib0005","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis: a european multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2024.101107_bib0006","first-page":"6","article-title":"Inflammation: a two-edged sword\u2013the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis"},{"issue":"2","key":"10.1016\/j.resmer.2024.101107_bib0007","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1378\/chest.128.2.739","article-title":"Quality-of-life determinants in patients with clinically stable bronchiectasis","volume":"128","author":"Martinez-Garcia","year":"2005","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.resmer.2024.101107_bib0008","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.chest.2020.06.050","article-title":"Airway clearance techniques in bronchiectasis: analysis from the United States bronchiectasis and non-TB mycobacteria research registry","volume":"158","author":"Basavaraj","year":"2020","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.resmer.2024.101107_bib0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/resp.13459","article-title":"Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis","volume":"24","author":"O'Neill","year":"2019","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.resmer.2024.101107_bib0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/089426802760292681","article-title":"Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction","volume":"15","author":"Daviskas","year":"2002","journal-title":"J Aerosol Med"},{"issue":"1","key":"10.1016\/j.resmer.2024.101107_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/JCI119138","article-title":"Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea","volume":"99","author":"Wills","year":"1997","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.resmer.2024.101107_bib0012","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1440-1843.2003.00454.x","article-title":"Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum","volume":"8","author":"Shibuya","year":"2003","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.resmer.2024.101107_bib0013","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.resmer.2024.101107_bib0014","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201101-0072OC","article-title":"Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis","volume":"183","author":"Reeves","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2024.101107_bib0015","first-page":"50","article-title":"Chest physiotherapy in European patients with bronchiectasis: data from the EMBARC registry","author":"Cortina","year":"2017","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.resmer.2024.101107_bib0016","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.resmer.2024.101107_bib0017","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1016\/j.resmer.2024.101107_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rmed.2004.05.006","article-title":"Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis","volume":"99","author":"Kellett","year":"2005","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.resmer.2024.101107_bib0019","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/resp.13047","article-title":"Mucoactive agents for chronic, non-cystic fibrosis lung disease: a systematic review and meta-analysis","volume":"22","author":"Tarrant","year":"2017","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.resmer.2024.101107_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002996","article-title":"Inhaled hyperosmolar agents for bronchiectasis","author":"Wills","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.resmer.2024.101107_bib0021","article-title":"Inhaled hyperosmolar agents for bronchiectasis","author":"Hart","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.resmer.2024.101107_bib0022","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","volume":"2015","author":"Welsh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.resmer.2024.101107_bib0023","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.resmer.2024.101107_bib0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.resmer.2024.101107_bib0025","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.resmer.2024.101107_bib0026","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"10.1016\/j.resmer.2024.101107_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.resmer.2024.101107_bib0028","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/resp.14479","article-title":"Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand","volume":"28","author":"Chang","year":"2023","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.resmer.2024.101107_bib0029","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01610-2019","article-title":"Respiratory physiotherapy in the bronchiectasis guidelines: is there a loud voice we are yet to hear?","volume":"54","author":"Spinou","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.resmer.2024.101107_bib0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2022","article-title":"European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis","volume":"62","author":"Herrero-Cortina","year":"2023","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.resmer.2024.101107_bib0031","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.chest.2020.07.062","article-title":"Using airway clearance techniques in bronchiectasis: halfway there","volume":"158","author":"Spinou","year":"2020","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.resmer.2024.101107_bib0032","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \"Frequent Exacerbator Phenotype\" in Bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Resp Crit Care"},{"issue":"5","key":"10.1016\/j.resmer.2024.101107_bib0033","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000381289","article-title":"Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with non-cystic fibrosis bronchiectasis","volume":"89","author":"Maiz","year":"2015","journal-title":"Respiration"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T08:03:20Z","timestamp":1734163400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041224000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"alternative-id":["S2590041224000230"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101107","relation":{},"ISSN":["2590-0412"],"issn-type":[{"type":"print","value":"2590-0412"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM research registry","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SPLF and Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101107"}}